Editorial & Opinion
Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series.
| العنوان: | Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series. |
|---|---|
| المؤلفون: | Fatobene G; Sírio-Libanês Hospital, São Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo da Universidade de São Paulo (ICESP USP), São Paulo, SP, Brazil; Laboratório Investigação Médica em Patogênese e Terapia dirigida em Onco-Imuno-Hematologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (LIM/31 HCFMUSP), São Paulo, SP, Brazil. Electronic address: giancarlo.fatobene@hsl.org.br., Souza GR; Sírio-Libanês Hospital, São Paulo, SP, Brazil., Rodrigues CA; Sírio-Libanês Hospital, São Paulo, SP, Brazil., Novis YAS; Sírio-Libanês Hospital, São Paulo, SP, Brazil., Rocha V; Sírio-Libanês Hospital, São Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo da Universidade de São Paulo (ICESP USP), São Paulo, SP, Brazil; Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil; Churchill Hospital, Oxford University Hospitals, United Kingdom; Laboratório Investigação Médica em Patogênese e Terapia dirigida em Onco-Imuno-Hematologia do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (LIM/31 HCFMUSP), São Paulo, SP, Brazil. |
| المصدر: | Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2021 Oct-Dec; Vol. 43 (4), pp. 532-536. Date of Electronic Publication: 2020 Sep 13. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 101725732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-1387 (Electronic) Linking ISSN: 25311379 NLM ISO Abbreviation: Hematol Transfus Cell Ther Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Rio de Janeiro, Brazil] : Elsevier Editora Ltda, [2018]- |
| References: | Leukemia. 2003 Feb;17(2):468-70. (PMID: 12592351) Leukemia. 2008 Dec;22(12):2284-5. (PMID: 18563175) Cancer Chemother Pharmacol. 2002 Dec;50(6):497-500. (PMID: 12451477) Leukemia. 2007 Jan;21(1):66-71. (PMID: 17051246) Ann Hematol. 2018 Jul;97(7):1115-1153. (PMID: 29680875) Oncologist. 2019 May;24(5):e171-e179. (PMID: 30898889) Ther Adv Hematol. 2011 Apr;2(2):73-82. (PMID: 23556078) Lancet. 2012 Apr 21;379(9825):1508-16. (PMID: 22482940) Blood. 1998 Aug 1;92(3):795-801. (PMID: 9680347) Haematologica. 2019 Jan;104(1):7-9. (PMID: 30598494) |
| تواريخ الأحداث: | Date Created: 20201015 Latest Revision: 20211111 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC8573029 |
| DOI: | 10.1016/j.htct.2020.07.008 |
| PMID: | 33055008 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 2531-1387 |
|---|---|
| DOI: | 10.1016/j.htct.2020.07.008 |